What's New

What the data tell us: projections for the HIV epidemic in AP region in 2030 and beyond  

UNAIDS' Data Book - HIV country profiles provide an overview of the latest available data on the HIV epidemic and response in the countries from 2024.

The People Living with HIV Stigma Index is a standardized tool to gather evidence on how stigma and discrimination impact the lives of people living with HIV. It was developed to provide much-needed data and evidence that could be used to advocate for the rights of people living with and affected by HIV. The results of HIV Stigma Index 2.0 in Thailand are now available.

The 2024 Population Size Estimation (PSE) exercise followed a geographical mapping approach similar to the 2010 and 2016 exercises. In addition, three other methods were used to estimate the size of key populations: the capture-recapture method, network scale-up, and service multiplier methods. This survey aimed to generate both sub-national and national level estimates of the size of key populations targeted by HIV-related interventions managed at the district level in collaboration with national, local partners, and community organizations.

A successful AIDS response should be measured by the achievement of concrete, timebound targets, accompanied by careful monitoring of the progress in implementing the commitments of the 2021 Political Declaration on AIDS. The Global AIDS Monitoring (GAM) framework helps to structure and organize collective global monitoring efforts. It is based on the structure of the Political Declaration, using eight core focus areas, linked to three global AIDS strategic priorities.

This report focuses on one of these essentials—the central role of human rights as it relates to ensuring access to HIV prevention and treatment services and addressing the structural determinants that increase vulnerability to HIV.  

Tuberculosis (TB) is a preventable and usually curable disease. Yet in 2023, TB probably returned to being the world’s leading cause of death from a single infectious agent, following 3 years in which it was replaced by coronavirus disease (COVID-19), and caused almost twice as many deaths as HIV/AIDS.

In April 2024, the World Health Organization (WHO) updated its guidelines for the prevention, care, diagnosis, and treatment of people with chronic hepatitis B infection, which are aimed at helping policymakers and healthcare providers in low- and middle-income countries strengthen their efforts to address hepatitis B virus (HBV) and related national responses. The guidelines can also be used by civil society and community organizations to advocate for access to prevention, diagnosis, and treatment of HBV.  This fact sheet summarizes the primary messages and recommendations.

This report shows that world leaders can fulfil their promise to end AIDS as a public health threat by 2030, and in so doing prevent millions of AIDS-related deaths, prevent millions of new HIV infections, and ensure the almost 40 million people living with HIV have healthy, full lives. Through powerful case studies and new data, the report shows how some countries are already on the right path—and how all countries can get on it.  

In 2023, 6.6 million [6.1 million–7.5 million] people living with HIV were residing in Asia and the Pacific, making this the world’s largest epidemic after eastern and southern Africa. The region accounts for a quarter of annual new HIV infections globally (23%). People from key populations and their sex partners are disproportionately affected. Among countries with available data, HIV epidemics are growing in Afghanistan, Bangladesh, Fiji, the Lao People’s Democratic Republic, Papua New Guinea and the Philippines. Between 2010 and 2022, numbers of new HIV infections increased by 32% among gay men and other men who have sex with men and by 85% among non-client sex partners of people from key populations.